Tag: Cancer: Pancreatic
ASCO: mFOLFIRINOX Improves Survival in Pancreatic Cancer
And, pre-op chemoradiotherapy linked to longer overall survival than immediate surgery
Worse Survival for BRCA Germline Mutation Carriers in Pancreatic CA
For BRCA germline mutation carriers, better survival seen with platinum-based chemotherapy
Calcium Channel Blockers May Up Pancreatic Cancer Risk in Women
Increased hazard ratios for pancreatic cancer among postmenopausal users of short-acting CCBs
Upper Abdominal Cancer Resections Up in Octogenarians
Increase in resection rates driven by trends in hepatic and pancreatic resections
Mechanisms ID’d for Curcumin Resensitization of Cancer Cells
Compound helps turn off pathways linked to chemoresistance in pancreatic ductal adenocarcinoma
Chemo Plus Hyperthermia Active in Advanced Pancreatic Cancer
Systemic and intraperitoneal chemotherapy + hyperthermia well tolerated and active
Blood Test for Early Detection of Pancreatic Cancer Feasible
Test screens for two biomarkers: thrombospondin-2 and CA19-9.
Blood Test for Earlier Detection of Pancreatic Cancer Feasible
Test uses chip technology that analyzes circulating tumor-derived extracellular vesicles
Traveling to Academic Hospital May Be Best for Pancreatic Cancer
Academic medical centers that perform more tumor surgeries have better patient outcomes
ASCO Updates Recs on Potentially Curable Pancreatic Cancer
Regimen of gemcitabine, capecitabine preferred in absence of concerns for toxicity, tolerance
